Merck tightens manufacturing supply chain; Cheap HPV vaccines may appear without patent infringement;

> Merck is realigning its global manufacturing network to create a focused, more fully-utilized and cost-efficient worldwide supply chain. Release

> Study says vaccine makers from developing countries may be able to produce an HPV vaccine at low cost without infringing patents. Article

> Contract manufacturer AAIPharma and nanotech supplier CritiTech have allied to offer biopharma companies an alternative to conventional parenteral administration that aims to improve the delivery of molecules having low aqueous solubility or poor bioavailability. Article

> OctoPlus will perform process development and clinical manufacturing for The Medicines Co's MDCO-216 drug candidate. Announcement

> Amneal Pharmaceuticals has named Shankar Hariharan chief scientific officer/exec VP for specialty pharmaceuticals. Release

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.